Medications Development for the Treatment of Cannabis Related Disorders

NCT01204723 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Withdrawal
Marijuana Dependence
Cannabis Dependence
Nicotine Dependence
Cannabis Abuse

Interventions

DRUG: Placebo Aprepitant
DRUG: Active Aprepitant

Sponsor

University of Virginia

Collaborators

[object Object]